(Q35141452)

6 August 2017

1 reference

title

Estrogen as neuroprotectant of nigrostriatal dopaminergic system: laboratory and clinical studies (English)

1 reference

6 August 2017

1 reference

Dean Dluzen

1

1 reference

PubMed ID

12777705

6 August 2017

Martin Horstink

series ordinal

2

1 reference

6 August 2017

1 June 2003

1 reference

6 August 2017

1 reference

6 August 2017

21

1 reference

6 August 2017

1

1 reference

6 August 2017

67-75

1 reference

https://scigraph.springernature.com/pub.10.1385/endo:21:1:67

6 August 2017

0 references

cites work

Estrogen use among nursing home residents with a diagnosis of Parkinson's disease

1 reference

12 December 2020

[Angiodysplasia of moya-moya type disclosed by choreic unvoluntary abnormal movements during oral contraception. Apropos of 2 cases]

1 reference

12 December 2020

Hysterectomy, menopause, and estrogen use preceding Parkinson's disease: an exploratory case-control study.

1 reference

12 December 2020

Effects of female sex steroids on Parkinson's disease in postmenopausal women.

1 reference

12 December 2020

Estrogen as a neuroprotectant against MPTP-induced neurotoxicity in C57/B1 mice.

1 reference

12 December 2020

Influence of gonadal hormones on sexual differences in sensitivity to methamphetamine-induced neurotoxicity

1 reference

12 December 2020

Sex differences and estrous cycle variations in amphetamine-elicited rotational behavior.

1 reference

12 December 2020

1 reference

12 December 2020

Stereotyped behavior elicited by amphetamine in the rat: influences of the testes

1 reference

12 December 2020

Tardive dyskinesia in patients treated with major neuroleptics: a review of the literature

1 reference

12 December 2020

Worldwide occurrence of Parkinson's disease: an updated review

1 reference

12 December 2020

Quantitative microdialysis determination of extracellular striatal dopamine concentration in male and female rats: effects of estrous cycle and gonadectomy

1 reference

12 December 2020

Epidemiology of Parkinson's disease.

1 reference

12 December 2020

Variations in the uptake of 3H-dopamine during the estrous cycle

1 reference

12 December 2020

Modulation of brain dopamine transmission by sex steroids

1 reference

12 December 2020

1 reference

12 December 2020

Effects of estrogen on the basal ganglia

1 reference

12 December 2020

1 reference

12 December 2020

The effect of testosterone upon methamphetamine neurotoxicity of the nigrostriatal dopaminergic system

1 reference

12 December 2020

Risk factors of Parkinson's disease in Indian patients

1 reference

12 December 2020

Changes of rat striatal neuronal membrane morphology and steroid content during the estrous cycle

1 reference

12 December 2020

Risk tables for parkinsonism and Parkinson's disease.

1 reference

12 December 2020

The placebo effect in Parkinson's disease

1 reference

12 December 2020

Gender differences in dopaminergic function in striatum and nucleus accumbens

1 reference

12 December 2020

Parkinson's disease and parkinsonism in a longitudinal study: two-fold higher incidence in men. ILSA Working Group. Italian Longitudinal Study on Aging.

1 reference

12 December 2020

Differential effects of estrogen and androgen on locomotor activity induced in castrated male rats by amphetamine, a novel environment, or apomorphine

1 reference

12 December 2020

1 reference

12 December 2020

Ovarian hormones do not attenuate methamphetamine-induced dopaminergic neurotoxicity in mice gonadectomized at 4 weeks postpartum.

1 reference

12 December 2020

The oestrous cycle and monoamine oxidase activity

1 reference

12 December 2020

Neurology of sex steroids and oral contraceptives

1 reference

12 December 2020

1 reference

12 December 2020

Chorea associated with oral contraception

1 reference

12 December 2020

Short-term effects of high-dose 17beta-estradiol in postmenopausal PD patients: a crossover study

1 reference

12 December 2020

Changes in brain monoamine concentrations during the oestrous cycle in the mouse: possible pharmacological implications.

1 reference

12 December 2020

Sexual differences and estrous cycle in methamphetamine-induced dopamine and serotonin depletions in the striatum of mice

1 reference

12 December 2020

The dopamine-depleting effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in CD-1 mice are gender-dependent.

1 reference

12 December 2020

Gender ratio differences between Parkinson's disease patients and their affected relatives

1 reference

12 December 2020

Behavioral effects of dopamine agonists and antagonists: influence of estrous cycle, ovariectomy, and estrogen replacement in rats.

1 reference

12 December 2020

In vivo changes in responsiveness of the caudate nucleus to L-dopa infusion as a function of the estrous cycle.

1 reference

12 December 2020

Potentiation and inhibition of the amphetamine stereotypy in rats by neuroleptics and other agents

1 reference

12 December 2020

The Impact of Gender and Estrogen on Striatal Dopaminergic Neurotoxicity

1 reference

12 December 2020

The effect of estrogen replacement on early Parkinson's disease

1 reference

12 December 2020

Tamoxifen diminishes methamphetamine-induced striatal dopamine depletion in intact female and male mice

1 reference

12 December 2020

Sex differences in the amphetamine stimulated release of catecholamines from rat striatal tissue in vitro

1 reference

12 December 2020

Prevalence of Parkinson's disease in Cantalejo, Spain: a door-to-door survey.

1 reference

12 December 2020

Gender differences in neurotoxicity of the nigrostriatal dopaminergic system: implications for Parkinson's disease.

1 reference

12 December 2020

Sex and estrous cycle variations of rat striatal dopamine uptake sites.

1 reference

12 December 2020

Chorea gravidarum and chorea associated with oral contraceptives--diseases due to antiphospholipid antibodies?

1 reference

12 December 2020

Chronic dopaminergic sensitivity after Sydenham's chorea

1 reference

12 December 2020

Regional catecholamine content in the rat brain: Sex differences and correlation with motor activity

1 reference

12 December 2020

Prevalence of Parkinson's disease in the elderly: a population study in Gironde, France

1 reference

12 December 2020

Tamoxifen eliminates estrogen's neuroprotective effect upon MPTP-induced neurotoxicity of the nigrostriatal dopaminergic system

1 reference

12 December 2020

Chorea as the initial presentation of oral contraceptive induced systemic lupus erythematosus

1 reference

12 December 2020

Effect of estrogen and progesterone on L-dopa induced dyskinesia in MPTP-treated monkeys

1 reference

12 December 2020

Gonadectomy and sex differences in the behavioral responses to amphetamine and apomorphine of rats

1 reference

12 December 2020

Cyclic variations of catecholamine content in hypothalamic nerve cells during the estrous cycle of the rat, with a concomitant study of the substantia nigra

1 reference

12 December 2020

In vitro dopamine release from the rat striatum: diurnal rhythm and its modification by the estrous cycle.

1 reference

12 December 2020

Neuroprotective effects of estrogen upon the nigrostriatal dopaminergic system

1 reference

12 December 2020

Gender differences in Parkinson's disease

1 reference

12 December 2020

Estrogen and progesterone distinctively modulate methamphetamine-induced dopamine and serotonin depletions in C57BL/6J mice

1 reference

12 December 2020

Striatal D-2 dopamine agonist binding sites fluctuate during the rat estrous cycle

1 reference

12 December 2020

Chorea induced by oral contraceptives

1 reference

12 December 2020

Prevalence of Parkinson's disease in the elderly: The Rotterdam Study

1 reference

12 December 2020

Changing epidemiology of Parkinson's disease in southwestern Finland

1 reference

12 December 2020

Ovarian steroids and raloxifene prevent MPTP-induced dopamine depletion in mice

1 reference

12 December 2020

Sex differences in catecholamine content in discrete brain nuclei of the rat: effects of neonatal castration or testosterone treatment.

1 reference

12 December 2020

Neuroprotective role of estrogen upon methamphetamine and related neurotoxins within the nigrostriatal dopaminergic system

1 reference

12 December 2020

Estrogen and Parkinson's disease

1 reference

12 December 2020

Diagnostic and therapeutic problems in two patients with antiphospholipid antibodies, heart valve lesions, and transient ischaemic attacks

1 reference

12 December 2020

Estrogens and the pathophysiology of Parkinson's disease

1 reference

12 December 2020

Sexual differences in sensitivity to methamphetamine toxicity

1 reference

12 December 2020

Association between early-onset Parkinson's disease and mutations in the parkin gene

1 reference

12 December 2020

Modification of postsynaptic dopaminergic sensitivity by female sex hormones

1 reference

12 December 2020

Gender-dependent enhanced adult neurotoxic response to methamphetamine following fetal exposure to the drug

1 reference

12 December 2020

Estrogen, anti-estrogen, and gender: differences in methamphetamine neurotoxicity.

1 reference

12 December 2020

The influence of estrous cycle and intrastriatal estradiol on sensorimotor performance in the female rat

1 reference

12 December 2020

Estrous cycle-dependent variation in amphetamine-induced behaviors and striatal dopamine release assessed with microdialysis

1 reference

12 December 2020

Modulatory effects of testosterone on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity.

1 reference

12 December 2020

Comparative study of the neuroprotective effect of dehydroepiandrosterone and 17beta-estradiol against 1-methyl-4-phenylpyridium toxicity on rat striatum

1 reference

12 December 2020

Estrogen decreases corpus striatal neurotoxicity in response to 6-hydroxydopamine.

1 reference

12 December 2020

Modifications of the striatal dopamine metabolism during the estrus cycle in mice

1 reference

12 December 2020

[Neuroleptics, parkinsonism and schizophrenia.]

1 reference

12 December 2020

Homovanillic acid levels in rat striatum during the oestrous cycle

1 reference

12 December 2020

Incidence and distribution of parkinsonism in Olmsted County, Minnesota, 1976-1990.

1 reference

12 December 2020

Estrogen alters MPTP-induced neurotoxicity in female mice: effects on striatal dopamine concentrations and release.

1 reference

12 December 2020

Tamoxifen abolishes estrogen's neuroprotective effect upon methamphetamine neurotoxicity of the nigrostriatal dopaminergic system

1 reference

12 December 2020

Chorea as the initial presentation of oral contraceptive related systemic lupus erythematosus

1 reference

12 December 2020

Effect of the rat estrous cycle at ovariectomy on striatal D-1 dopamine receptors.

1 reference

12 December 2020

Symptoms and duration of the prodromal phase in Parkinson's disease.

1 reference

12 December 2020

1 reference

12 December 2020

Effects of testosterone upon MPTP-induced neurotoxicity of the nigrostriatal dopaminergic system of C57/B1 mice.

1 reference

12 December 2020

No male predominance in alpha-synuclein Parkinson's disease but the affected female fetus might be less viable

1 reference

12 December 2020

Changes in catecholamine content in discrete brain nuclei during the estrous cycle of the rat

1 reference

12 December 2020

Progesterone action on the LHRH and the nigrostriatal dopamine neuronal systems: in vitro and in vivo studies.

1 reference

12 December 2020

Nigrostriatal and mesolimbic dopaminergic activities were modified throughout the ovarian cycle of female rats

1 reference

12 December 2020

Prevalence of Parkinson's disease in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group

1 reference

12 December 2020

Effects of orchidectomy on nigro-striatal dopaminergic function: behavioral and physiological evidence

1 reference

12 December 2020

Identifiers

DOI

10.1385/ENDO:21:1:67

1 reference

PubMed ID

12777705

Dimensions Publication ID

6 August 2017

0 references

1 reference

PubMed ID

12777705